JD Health (06618) Releases October 2025 Monthly Return on Movements in Securities

Bulletin Express

Nov 06

JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share capital remained USD 50,000, with 100,000,000,000 ordinary shares at a par value of USD 0.0000005 each. The issued share count stood at 3,201,475,111, unchanged from the previous month, and there were no treasury shares.

Under the Pre-IPO ESOP, 8,856,023 options were exercised using previously issued shares, and 6,660 options lapsed. These exercises generated USD 4.43 in total. By the end of October, 11,387,260 share options remained outstanding in this scheme. Meanwhile, the Post-IPO Share Option Scheme had no new activity, leaving up to 312,708,211 shares permissible for issuance under that framework.

The Post-IPO Share Award Scheme reported 24,799,005 shares remaining available for issuance. The report was submitted by Director Dong Cao on November 6, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1129790280"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129790280\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129790280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129790280","market":"hk","top_or_hot":-1,"title":"JD Health (06618) Releases October 2025 Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share capital remained USD 50,000, with 100,000,000,000 ordinary shares at a par value of USD 0.0000005 each. The issued share count stood at 3,201,475,111, unchanged from the previous month, and there were no treasury shares.</p>\n<p>Under the Pre-IPO ESOP, 8,856,023 options were exercised using previously issued shares, and 6,660 options lapsed. These exercises generated USD 4.43 in total. By the end of October, 11,387,260 share options remained outstanding in this scheme. Meanwhile, the Post-IPO Share Option Scheme had no new activity, leaving up to 312,708,211 shares permissible for issuance under that framework.</p>\n<p>The Post-IPO Share Award Scheme reported 24,799,005 shares remaining available for issuance. The report was submitted by Director Dong Cao on November 6, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health (06618) Releases October 2025 Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health (06618) Releases October 2025 Monthly Return on Movements in Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-06 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share capital remained USD 50,000, with 100,000,000,000 ordinary shares at a par value of USD 0.0000005 each. The issued share count stood at 3,201,475,111, unchanged from the previous month, and there were no treasury shares.</p>\n<p>Under the Pre-IPO ESOP, 8,856,023 options were exercised using previously issued shares, and 6,660 options lapsed. These exercises generated USD 4.43 in total. By the end of October, 11,387,260 share options remained outstanding in this scheme. Meanwhile, the Post-IPO Share Option Scheme had no new activity, leaving up to 312,708,211 shares permissible for issuance under that framework.</p>\n<p>The Post-IPO Share Award Scheme reported 24,799,005 shares remaining available for issuance. The report was submitted by Director Dong Cao on November 6, 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1129790280","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129790280","pubTimestamp":1762419256,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康(06618)发布2025年10月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share capital remained USD 50,000, with 100,000,000,000 ordinary shares at a par value of USD 0.0000005 each. The issued share count stood at 3,201,475,111, unchanged from the previous month, and there were no treasury shares.\nUnder the Pre-IPO ESOP, 8,856,023 options were exercised using previously issued shares, and 6,660 options lapsed. These exercises generated USD 4.43 in total. By the end of October, 11,387,260 share options remained outstanding in this scheme. Meanwhile, the Post-IPO Share Option Scheme had no new activity, leaving up to 312,708,211 shares permissible for issuance under that framework.\nThe Post-IPO Share Award Scheme reported 24,799,005 shares remaining available for issuance. The report was submitted by Director Dong Cao on November 6, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}